Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Research output: Contribution to journalComment/Letter to the editorAcademic

LanguageEnglish
JournalBritish Journal of Clinical Pharmacology
DOIs
Publication statusPublished - 2019

Cite this

@article{0a51241b8ca4444788807e7e7bccc9c8,
title = "Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?",
author = "Peters, {Godefridus J.} and Elisa Giovannetti and Honeywell, {Richard J.} and Joseph Ciccolini",
year = "2019",
doi = "10.1111/bcp.13921",
language = "English",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

AU - Peters, Godefridus J.

AU - Giovannetti, Elisa

AU - Honeywell, Richard J.

AU - Ciccolini, Joseph

PY - 2019

Y1 - 2019

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065098905&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30866103

U2 - 10.1111/bcp.13921

DO - 10.1111/bcp.13921

M3 - Comment/Letter to the editor

JO - British Journal of Clinical Pharmacology

T2 - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

ER -